MENU
+Compare
PGEN
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$1.91
Change
-$0.06 (-3.05%)
Capitalization
554.99M

PGEN Precigen Forecast, Technical & Fundamental Analysis

a biotechnology company, which engages in the research and development of synthetic biology technologies.

Industry Biotechnology
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for PGEN with price predictions
Feb 20, 2025

PGEN's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for PGEN turned positive on February 05, 2025. Looking at past instances where PGEN's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 23, 2025. You may want to consider a long position or call options on PGEN as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for PGEN moved above the 200-day moving average on February 20, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PGEN advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 142 cases where PGEN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PGEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PGEN broke above its upper Bollinger Band on February 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PGEN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.020) is normal, around the industry mean (12.644). P/E Ratio (0.000) is within average values for comparable stocks, (84.748). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.591). PGEN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (123.457) is also within normal values, averaging (254.739).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PGEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PGEN is expected to report earnings to fall 26.67% to -6 cents per share on February 26

Precigen PGEN Stock Earnings Reports
Q4'24
Est.
$-0.07
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.13
Q1'24
Missed
by $0.01
Q4'23
Missed
by $0.05
The last earnings report on November 14 showed earnings per share of -9 cents, missing the estimate of -7 cents. With 1.13M shares outstanding, the current market capitalization sits at 554.99M.
A.I. Advisor
published General Information

General Information

a biotechnology company, which engages in the research and development of synthetic biology technologies.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
20374 Seneca Meadows Parkway
Phone
+1 301 556-9900
Employees
202
Web
http://www.precigen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LLINX15.65N/A
N/A
Longleaf Partners International
JFGAX10.42N/A
N/A
JHancock Fundamental Global Fran A
GDEUX23.58N/A
N/A
Goldman Sachs U.S. Equity ESG R6
STEYX13.85N/A
N/A
AB International Strat Eqs Adv
ACFNX74.01N/A
N/A
American Century Focused Dynamic Gr R6

PGEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with RCKT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGEN
1D Price
Change %
PGEN100%
-2.96%
RCKT - PGEN
43%
Loosely correlated
-0.46%
NKTX - PGEN
42%
Loosely correlated
-6.11%
ALEC - PGEN
41%
Loosely correlated
+1.64%
AVIR - PGEN
40%
Loosely correlated
+1.62%
IDYA - PGEN
40%
Loosely correlated
+5.18%
More